Neumora Therapeutics, Inc. Common Stock (NMRA) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q4'20 |
|---|
| Total Current Assets | 153.43M | 190.54M | 177.08M | 222.91M | 254.87M | 314.06M | 348.61M | 398.32M | 442.79M | 478.28M | 525.74M | 336.61M | 359.96M | 387.95M | 340.39M | 362.92M | 415.6M | 443.08M | 193.84M |
| Cash & Short-Term Investments | 147.07M | 182.53M | 171.53M | 217.59M | 249.35M | 307.58M | 341.31M | 371.64M | 422.71M | 453.98M | 509.56M | 324.2M | 345.55M | 371.88M | 327.51M | 349.62M | 409.25M | 439.14M | 191.98M |
| Cash Only | 147.07M | 182.53M | 129.07M | 124.52M | 126.86M | 142.15M | 275.71M | 150.68M | 182.93M | 374.04M | 412.28M | 204.22M | 210.87M | 240.94M | 174.4M | 291.18M | 409.25M | 439.14M | 191.98M |
| Short-Term Investments | 0 | 0 | 42.45M | 93.06M | 122.49M | 165.43M | 65.59M | 220.96M | 239.79M | 79.94M | 97.28M | 119.98M | 134.68M | 130.94M | 153.11M | 58.44M | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.63M | 906K | 939K | 668K | 594K | 787K | 919K | 585K | 269K | 200K | 270K | 148K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.36M | 8.01M | 5.56M | 5.32M | 5.51M | 6.48M | 7.3M | 0 | 0 | 0 | 0 | 0 | 13.63M | 50K | 50K | 50K | 125K | 125K | 125K |
| Total Non-Current Assets | 443K | 510K | 751K | 916K | 1.88M | 2.92M | 3.93M | 6.15M | 7.43M | 17.92M | 19.01M | 23.34M | 32.13M | 38.28M | 23.19M | 19.91M | 13.69M | 8.89M | 4.11M |
| Property, Plant & Equipment | 390K | 457K | 554K | 618K | 1.88M | 2.92M | 3.93M | 4.94M | 5.91M | 6.86M | 7.89M | 8.68M | 9.71M | 10.64M | 9.7M | 3.8M | 4.04M | 4.5M | 3.92M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 302K | 9.85M | 9.91M | 9.89M | 19.5M | 23.51M | 9.37M | 13.81M | 0 | 0 | 0 |
| Other Non-Current Assets | 53K | 53K | 197K | 298K | 0 | 0 | 0 | 1.21M | 1.21M | 1.21M | 1.21M | 4.77M | 2.93M | 4.13M | 4.13M | 2.3M | 9.65M | 4.39M | 183K |
| Total Assets | 153.88M | 191.05M | 177.83M | 223.82M | 256.75M | 316.97M | 352.54M | 404.47M | 450.21M | 496.19M | 544.75M | 359.95M | 392.09M | 426.23M | 363.58M | 382.84M | 429.3M | 451.98M | 197.95M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -40.07% | -39.73% | -49.56% | -44.66% | -42.97% | -36.12% | -35.28% | 12.37% | 14.82% | 16.41% | - | -1% | 2.42% | -0.71% | - | - | 116.88% | - | - |
| Total Current Liabilities | 30.11M | 32.45M | 25.84M | 21.16M | 28.38M | 29.89M | 31.74M | 23.13M | 24.61M | 25.11M | 29.12M | 26.09M | 21.78M | 23.7M | 22.86M | 17.93M | 23.28M | 20.95M | 9.37M |
| Accounts Payable | 5.06M | 3.38M | 549K | 644K | 1.05M | 3.31M | 6.11M | 1.08M | 1.49M | 337K | 2.23M | 8.17M | 1.14M | 7.15M | 3.02M | 1.65M | 1.64M | 2.51M | 2.4M |
| Days Payables Outstanding | 47.45K | - | 10.98 | - | - | - | - | - | - | 711.06 | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 291K | 284K | 256K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.35M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 24.77M | 28.79M | 25.04M | 6.73M | 6.28M | 10.11M | 22.89M | 7.59M | 4.79M | 10.15M | 9.73M | 6.95M | 17.3M | 10.04M | 7.02M | 4.26M | 8.13M | 6.06M | 4.13M |
| Current Ratio | 5.09x | 5.87x | 6.85x | 10.54x | 8.98x | 10.51x | 10.98x | 17.22x | 17.99x | 19.05x | 18.05x | 12.90x | 16.53x | 16.37x | 14.89x | 20.24x | 17.85x | 21.15x | 20.69x |
| Quick Ratio | 5.09x | 5.87x | 6.85x | 10.54x | 8.98x | 10.51x | 10.98x | 17.22x | 17.99x | 19.05x | 18.05x | 12.90x | 16.53x | 16.37x | 14.89x | 20.24x | 17.85x | 21.15x | 20.69x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 53.08M | 54.73M | 19.83M | 19.79M | 0 | 22K | 55K | 89K | 1.06M | 2.01M | 2.93M | 847.4M | 4.55M | 849.39M | 735.43M | 730.93M | 731.24M | 731.47M | 282.96M |
| Long-Term Debt | 119K | 193K | 267K | 19.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 339K | 0 | 0 | 0 | 0 | 938K | 1.85M | 2.75M | 3.5M | 4.29M | 5.07M | 4.79M | 723K | 996K | 1.32M | 1.28M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 52.96M | 54.53M | 19.56M | 0 | 0 | 22K | 55K | 89K | 122K | 155K | 188K | 843.91M | 254K | 844.32M | 730.64M | 730.2M | 730.24M | 730.15M | 281.68M |
| Total Liabilities | 83.2M | 87.18M | 45.67M | 40.95M | 28.38M | 29.91M | 31.8M | 23.21M | 25.67M | 27.12M | 32.06M | 873.49M | 26.33M | 873.08M | 758.29M | 748.85M | 754.52M | 752.42M | 292.33M |
| Total Debt | 410K | 477K | 523K | 19.96M | 938K | 1.85M | 2.75M | 3.61M | 4.43M | 5.23M | 6.14M | 6.82M | 7.64M | 8.44M | 7.38M | 1.76M | 2.05M | 2.55M | 2.04M |
| Net Debt | -146.66M | -182.05M | -128.55M | -104.56M | -125.92M | -140.29M | -272.97M | -147.07M | -178.5M | -368.81M | -406.14M | -197.4M | -203.23M | -232.5M | -167.02M | -289.41M | -407.19M | -436.59M | -189.93M |
| Debt / Equity | 0.01x | 0.00x | 0.00x | 0.11x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | - | 0.02x | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -28.51x | -28.20x | -74.98x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 70.68M | 103.87M | 132.16M | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M | 512.69M | -513.54M | 365.77M | -446.85M | -394.71M | -366.02M | -325.22M | -300.45M | -94.38M |
| Equity Growth % | -69.05% | -63.82% | -58.79% | -52.03% | -46.21% | -38.8% | -37.44% | 174.24% | 16.07% | 204.97% | - | -30.11% | 199.93% | -37.4% | - | - | -244.57% | - | - |
| Book Value per Share | 0.39 | 0.64 | 0.82 | 1.13 | 1.41 | 1.78 | 2.01 | 2.40 | 2.69 | 2.95 | 3.30 | -3.38 | 2.41 | -2.94 | -2.60 | -2.41 | -2.14 | -1.98 | -0.62 |
| Total Shareholders' Equity | 70.68M | 103.87M | 132.16M | 182.88M | 228.36M | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M | 512.69M | -513.54M | 365.77M | -446.85M | -394.71M | -366.02M | -325.22M | -300.45M | -94.38M |
| Common Stock | 18K | 17K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 16K | 15K | 3K | 16K | 3K | 15K | 15K | 3K | 13K | 13K |
| Retained Earnings | -1.24B | -1.18B | -1.12B | -1.07B | -1.02B | -947.22M | -888.4M | -815.86M | -757.15M | -703.43M | -594.7M | -541.68M | -503.13M | -467.51M | -410.02M | -379.65M | -336.61M | -309.64M | -99.29M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 9K | -15K | -3K | 62K | 105K | -187K | -148K | -76K | -311K | -448K | -298K | -774K | -870K | -178K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |